Inventor · disambiguated record
Markus Münz
Also filed as: MÜNZ MARKUS
6 granted patents·5 pending applications·49 citations·filing 2015–2025
81Inventor score
Files withAMGEN RES MUNICH GMBH11
Top patents by PatentIndex Score
11 records- 0195US10301391B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted May 28, 2019·28 cites·19 claims
- 0292US10781264B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 22, 2020·8 cites·22 claims
- 0391US11434302B2Bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2017·Granted Sep 6, 2022·7 cites·19 claims
- 0487US11661462B2Optimized cross-species specific bispecific single chain antibody contructsAMGEN RES MUNICH GMBH·Filed 2015·Granted May 30, 2023·4 cites·12 claims
- 0584US11352433B2BCMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2019·Granted Jun 7, 2022·2 cites·23 claims
- 0675US2025333535A1Bispecific single chain antibody construct with enhanced tissue distributionAMGEN RES MUNICH GMBH·Filed 2024·Application pending·0 cites
- 0772US2023192884A1Bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2022·Application pending·0 cites
- 0869US12428491B2PSMA and CD3 bispecific T cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2020·Granted Sep 30, 2025·0 cites·28 claims
- 0968US2025333537A1Psma and cd3 bispecific t cell engaging antibody constructsAMGEN RES MUNICH GMBH·Filed 2025·Application pending·0 cites
- 1056US2019169295A1Long life polypeptide binding moleculesAMGEN RES MUNICH GMBH·Filed 2018·Application pending·0 cites
- 1141US2017275373A1Bispecific single chain antibody construct with enhanced tissue distributionAMGEN RES MUNICH GMBH·Filed 2015·Application pending·0 cites
Identity basis: PatentsView inventor disambiguation (2025Q4-odp release). How scoring works →